Jeff Yang

Title: The Innovative Contributions of Jeff Yang

Introduction

Jeff Yang is a notable inventor based in Bethesda, MD (US). He has made significant strides in the field of biotechnology, particularly in the development of methods for detecting specific cellular components. His work has implications for various medical applications, showcasing his commitment to advancing scientific knowledge.

Latest Patents

Jeff Yang holds a patent for "Binding proteins and chimeric antigen receptor T cells targeting GASP-1 granules and uses thereof." This patent describes a method for detecting cells that have granules expressing G protein coupled receptor-associated sorting protein 1 (GASP-1). The detection method involves contacting the cells with a binding protein that specifically binds to GASP-1 and identifying the cells that have granules bound to this protein. The GASP-1 granules can be located in the cytosol or on the surface of the cells. Additionally, the patent outlines methods for producing T-cells that incorporate a chimeric antigen receptor, anti-GASP-1 antibody, or a bi-specific binding protein. It also provides methods for treating diseases mediated by GASP-1 or inactivating exosomes, microvesicles, or oncosomes.

Career Highlights

Jeff Yang is currently associated with Proplex Technologies, LLC, where he continues to innovate and contribute to the field of biotechnology. His work is characterized by a focus on practical applications of his inventions, aiming to improve diagnostic and therapeutic strategies.

Collaborations

Some of his notable coworkers include Frank N Chang and George P Tuszynski. Their collaborative efforts contribute to the advancement of research and development in their respective fields.

Conclusion

Jeff Yang's contributions to biotechnology through his innovative patent demonstrate his expertise and dedication to improving medical science. His work not only enhances our understanding of cellular mechanisms but also paves the way for potential therapeutic advancements.